Zacks Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-20,113
| Closed | -$1.19M | – | 548 |
|
|
2018
Q4 | $1.19M | Sell |
20,113
-871
| -4% | -$51.6K | 0.03% | 317 |
|
|
2018
Q3 | $1.38M | Buy |
20,984
+134
| +0.6% | +$8.82K | 0.03% | 343 |
|
|
2018
Q2 | $1.05M | Buy |
20,850
+417
| +2% | +$21.1K | 0.02% | 416 |
|
|
2018
Q1 | $1.08M | Buy |
20,433
+1,488
| +8% | +$78.4K | 0.02% | 395 |
|
|
2017
Q4 | $880K | Buy |
+18,945
| New | +$880K | 0.02% | 428 |
|
|
2016
Q3 | – | Sell |
-60,441
| Closed | -$1.7M | – | 669 |
|
|
2016
Q2 | $1.7M | Sell |
60,441
-43,200
| -42% | -$1.22M | 0.05% | 236 |
|
|
2016
Q1 | $3.77M | Buy |
103,641
+655
| +0.6% | +$23.8K | 0.12% | 148 |
|
|
2015
Q4 | $4.12M | Buy |
102,986
+3,470
| +3% | +$139K | 0.13% | 144 |
|
|
2015
Q3 | $2.84M | Buy |
99,516
+44,861
| +82% | +$1.28M | 0.1% | 162 |
|
|
2015
Q2 | $1.8M | Buy |
54,655
+192
| +0.4% | +$6.33K | 0.06% | 194 |
|
|
2015
Q1 | $1.57M | Buy |
54,463
+485
| +0.9% | +$13.9K | 0.05% | 209 |
|
|
2014
Q4 | $1.47M | Sell |
53,978
-1,946
| -3% | -$53K | 0.05% | 207 |
|
|
2014
Q3 | $1.19M | Sell |
55,924
-5,355
| -9% | -$114K | 0.04% | 221 |
|
|
2014
Q2 | $1.38M | Sell |
61,279
-18,467
| -23% | -$416K | 0.05% | 205 |
|
|
2014
Q1 | $2.02M | Buy |
+79,746
| New | +$2.02M | 0.07% | 176 |
|